Setting the Standard Since 1971
Cart 0

New IV Drug Compatibility & Stability - Winter 2021

In this update we added new monographs for ATEZOLIZUMAB and TRILACICLIB.

We also added new stability information to COVID-19 VACCINE, mRNA, and to 48 other existing drug monographs.

New compatibility information was added to these existing drug monographs: CEFEPIME HYDROCHLORIDE, CISATRACURIUM BESYLATE, DEXMEDETOMIDINE HYDROCHLORIDE, FENTANYL CITRATE, FOSPHENYTOIN, LEVETIRACETAM, NALOXONE HYDROCHLORIDE, NOREPINEPHRINE BITARTRATE, PIPERACILLIN AND TAZOBACTAM, PROPOFOL, VANCOMYCIN HYDROCHLORIDE, and VASOPRESSIN. View Past Updates...

Available for pre-order
2022 Y-Site Compatibility Wall Charts

This 27" x 27" poster is laminated and includes compatibility of 122 drugs and 4 infusion fluids updated with new data that has appeared in the complete King® Guide to Parenteral Admixtures®  throughout 2021.



Older Post